Centro risorse

Approfondimenti per i professionisti del farmaceutico

Approfondimenti su ricerca, innovazione e tendenze di mercato: il contesto dietro i titoli, scritto per chi lavora nel settore.

155 articoli nel centro
How Paper Chromatography Works: Capillary Action and Solvent Separation ExplainedRicerca

How Paper Chromatography Works: Capillary Action and Solvent Separation Explained

Uncover how paper chromatography uses capillary action and solvent separation for reliable pharma R&D, QA, and QC analysis.

Ravindra Warang26 ago 2025
Solving Complex Analytical Challenges: A Practical Guide for Choosing RP vs. HILIC vs. Normal PhaseRicerca

Solving Complex Analytical Challenges: A Practical Guide for Choosing RP vs. HILIC vs. Normal Phase

A practical guide to selecting the right column and separation mode for polar analytes in chromatography.

Mrudula Kulkarni16 ago 2025
Understanding FDA Form 483 Observations (and How to Respond)Ricerca

Understanding FDA Form 483 Observations (and How to Respond)

Understand FDA Form 483, common violations, and how to respond effectively to prevent costly enforcement actions and warning letters.

Ravindra Warang13 ago 2025
Preventing FDA Warning Letters - Building a Compliance-First CultureInnovazione

Preventing FDA Warning Letters - Building a Compliance-First Culture

Learn how a compliance - first culture, proactive audits, and strong training programs can help you avoid costly FDA warning letters.

Ravindra Warang12 ago 2025
Real-World Examples of FDA Warning Letters (and What They Teach Us)Ricerca

Real-World Examples of FDA Warning Letters (and What They Teach Us)

Explore real FDA warning letter cases and the compliance lessons they teach to help your business prevent costly violations.

Ravindra Warang12 ago 2025
How to Write an Effective FDA Warning Letter ResponseRicerca

How to Write an Effective FDA Warning Letter Response

Follow this proven process to address FDA warning letters—meet deadlines, fix violations, and maintain compliance with confidence.

Ravindra Warang12 ago 2025
Creating Visibility for Indian Research: From Output to Global InfluenceRicerca

Creating Visibility for Indian Research: From Output to Global Influence

India needs a national publishing strategy to boost global impact, credibility, and equity in research.

Dr. Prashant Mishra11 ago 2025
5 Most Common Reasons for FDA Warning Letters (and How to Avoid Them)Ricerca

5 Most Common Reasons for FDA Warning Letters (and How to Avoid Them)

Avoid costly FDA warning letters by knowing the top violations—GMP, mislabeling, reporting failures and how to stay fully compliant.

Ravindra Warang11 ago 2025
Digitization in Pharma - Risk or Opportunity?Innovazione

Digitization in Pharma - Risk or Opportunity?

A deep dive into pharma’s digitization journey—challenges, progress, and what the future demands.

Chandrashekhar Rao5 ago 2025
Top Liquid Filling Machine Manufacturers in PharmaTendenze di mercato

Top Liquid Filling Machine Manufacturers in Pharma

Explore the 10 best liquid filling machine makers driving scalable, aseptic production for injectables across pharma and biotech.

Ravindra Warang3 ago 2025
FDA Accelerated Approval What’s Changing and Why It Matters for Rare DiseasesInnovazione

FDA Accelerated Approval What’s Changing and Why It Matters for Rare Diseases

Exploring the FDA’s evolving Accelerated Approval pathway and its implications for pharma innovation and regulatory alignment.

Dawn Stephenson31 lug 2025
Understanding IQ/OQ/PQ for Pharma Checkweighers: Qualification Without the StressRicerca

Understanding IQ/OQ/PQ for Pharma Checkweighers: Qualification Without the Stress

Your stress-free guide to IQ/OQ/PQ qualification for pharma checkweighers—compliance made practical.

Ravindra Warang21 lug 2025